Close Menu
Home › BioGx Lands CE Mark for Four Infectious Disease Tests

BioGx Lands CE Mark for Four Infectious Disease Tests

Apr 24, 2017
|
staff reporter

NEW YORK (GenomeWeb) – BioGx today announced that it has received CE-IVD marking for four real-time PCR-based tests for infectious disease.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In PCR

  1. Illumina, ArcherDx Expand Partnership on NGS IVD Tests

  2. UK Researchers Implement Diagnostics.ai System to Improve Infectious Disease Testing

    Premium

  3. Co-Diagnostics Joint Venture Gets Clearance in India for Five MDx Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.